Market Research Report: Hypervision Surgical Ltd
Company Overview
Name
Hypervision Surgical Ltd
Mission of the Company
Equipping clinicians with advanced computer-assisted tissue analysis for improved surgical precision and patient safety using AI-powered hyperspectral imaging.
When Was the Company Founded and by Whom
- Hypervision Surgical Ltd is a spin-out company formed from King's College London.
- Founded by a team of clinicians, medical imaging, and artificial intelligence (AI) experts.
Key People in the Company
- Michael Ebner: CEO & Co-Founder
- Royal Academy of Engineering (RAEng) Enterprise Fellow.
- Holds a PhD in medical image computing with over 6 years of R&D experience.
- Tom Vercauteren: CSO & Co-Founder
- Professor of Interventional Image Computing and RAEng Research Chair in Machine Learning.
- Sébastien Ourselin: Board Director & Co-Founder
- Chair of Healthcare Engineering with 500+ publications.
- Jonathan Shapey: Clinical Lead & Co-Founder
- Senior Clinical Lecturer and Consultant neurosurgeon.
- Martin Frost: Chairman of the Board
- Founder and former CEO of CMR Surgical.
- Raf Roelands: Board Director
- Experienced life science investor and operator.
- Daniel Dillinger: Board Director
- Medical doctor and Principal at Redalpine.
- Julie Devonshire: Board Observer
- Director of the Entrepreneurship Institute at King’s College London.
- Jaco Jacobs: Chief Operations Officer
- 15 years of safety-critical and medical product development experience.
- Josh Gibson: Head of Technology
- Specialist in advanced sensing platforms with a background in optical physics.
Where is the Company Headquartered
London Institute for Healthcare Engineering, 100 Lambeth Palace Road, London, SE1 7AR, United Kingdom.
Number of Employees
No information is available.
Revenue of the Company
No information is available.
What is the Company Known for
Hypervision Surgical Ltd is known for pioneering AI-powered hyperspectral imaging technology, making surgeries more precise, safer, and faster.
Products
What Products Do They Offer
- AI-Powered Hyperspectral Imaging System
High-Level Description of the Product
A non-contact and non-invasive optical imaging system designed for real-time tissue analysis during surgical procedures. Utilizes AI algorithms for high-accuracy tissue characterization.
Key Features of Each Product
- Safe Optical Imaging: Non-contact, non-invasive, and no need for exogenous contrast agents.
- Quantitative AI Imaging: Provides wide-field information on physiological tissue properties, including perfusion assessment.
- Tissue Differentiation: Real-time identification of tumor, normal tissue, nerves, and blood vessels.
- Hyperspectral Imaging: Splits light into multiple spectral bands, carrying diagnostic information ideal for objective tissue characterization.
Recent Developments
What Are the Recent Developments in the Company
- FDA Safer Technologies Program: Hypervision Surgical's first product has been accepted into the U.S. FDA’s Safer Technologies Program, expediting market readiness and delivery benefits.
- ISO 13485 Certification: Achieved certification, reinforcing commitment to quality and safety in the healthcare industry.
What Are the New Products Launched
No information is available specifically on new product launches.
What Are the New Features Added to the Existing Products
No information is available on specific new features added to the existing products.
Any New Partnerships
No information is available on new partnerships.
Conclusion
Hypervision Surgical Ltd is at the forefront of leveraging AI and hyperspectral imaging to enhance surgical procedures, continuously driving innovation and quality in healthcare technology while gaining important FDA and ISO recognitions for their efforts.
